Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential
According to TipRanks, Singh Chadha is a 4-star analyst with an average return of 3.2% and a 54.38% success rate. Singh Chadha covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Insulet, and Edwards Lifesciences.
Currently, the analyst consensus on Insulet is a Strong Buy with an average price target of $378.24.
Based on Insulet’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $706.3 million and a net profit of $87.6 million. In comparison, last year the company earned a revenue of $543.9 million and had a net profit of $77.5 million
Based on the recent corporate insider activity of 67 insiders, corporate insider sentiment is neutral on the stock. Last month, Frederick Wayne A.I. , a Director at PODD sold 1,851.00 shares for a total of $542,509.59.
